Long-term survival rates of some Acute Myeloid Leukemia patients could double with sensitive bone marrow test

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia (AML) by helping doctors identify if they might relapse up to three months earlier.

source https://www.sciencedaily.com/releases/2025/04/250428220307.htm